Revision history of "DRY CHEMISTRY IN PRECISION MEDICINE" (Q2044561)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 17:0717:07, 10 October 2024DG Regio talk contribs 60,550 bytes +11 Changed label, description and/or aliases in pt
  • curprev 17:0717:07, 10 October 2024DG Regio talk contribs 60,539 bytes +60 Set a claim value: summary (P836): INTRODUÇÃO DE FARMACOGENÉTICAS FARECHAS, NASCIDAS EM 2010, AGORA COM UMA PARTICIPAÇÃO NO MERCADO EM ITÁLIA DE 70 %, É UM LÍDER ABSOLUTO NO DOMÍNIO DA FARMACOGENÉTICA E DA PERSONALIZAÇÃO DO TRATAMENTO. ÁREA PRIORITÁRIA DE APLICAÇÃO DA INVESTIGAÇÃO DESENVOLVIDA PELA DIPECH PHARMACOGENETICS ÃO CANCER É UMA PRIORIDADE MAIOR. A sociedade apoia a sua própria investigação através da venda e do desenvolvimento de ensaios farmacogenéticos utilizados em medic...

7 March 2024

14 June 2023

10 June 2023

26 April 2023

8 April 2023

5 July 2022

  • curprev 08:2408:24, 5 July 2022DG Regio talk contribs 57,873 bytes +38,148 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,

13 June 2022

7 February 2022

24 January 2022

24 December 2021

23 December 2021

16 December 2021

2 November 2020

25 September 2020

17 July 2020

8 June 2020

24 March 2020

23 March 2020

  • curprev 09:0209:02, 23 March 2020DG Regio talk contribs 9,774 bytes +1,329 Created claim: summary (P836): INTRODUCTION OF PHARECH PHARMACOGENETICS, BORN IN 2010, NOW WITH A MARKET SHARE IN ITALY OF 70 %, IT IS AN ABSOLUTE LEADER IN THE FIELD OF PHARMACOGENETICS AND PERSONALISATION OF TREATMENT. PRIORITY AREA OF APPLICATION OF THE RESEARCH DEVELOPED BY DIPECH PHARMACOGENETICS ÃO CANCER IS A MAJOR PRIORITY. THE COMPANY SUPPORTS ITS OWN RESEARCH THROUGH THE SALE AND DEVELOPMENT OF PHARMACOGENETIC TESTS USED IN PERSONALISED AND GENETIC MEDICINE BASED O...

17 March 2020

12 March 2020

6 March 2020